Sign in
Taking people in United StatesNo phase

NightWare and Cardiovascular Health in Veterans With PTSD

Key facts

Who runs it
VA Office of Research and Development
Where
Aurora, United StatesSee the site
Trial code
Status
Recruiting
People taking part
125 people, planned
Started
10 Sept 2025
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • NightWare
Record updated
8 October 2026

Who can take part

Age
22 years to 88 years
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (22)Hide the full registry criteria

Who can take part

  • Diagnosis of Post-traumatic stress disorder (PTSD) via American Psychiatric Association PTSD diagnostic criteria in the fifth edition of its Diagnostic and Statistical Manual of Mental Disorders (DSM-5)
  • Self-report having repetitive nightmares contributing to disrupted sleep
  • Resting blood pressure (BP, <160/100 millimeters of mercury (mmHg)
  • Fasted glucose <126 milligrams per deciliter (mg/dL)
  • Poor overall sleep quality as indicated by a Pittsburgh Sleep Quality Index (PSQI) score 6 or higher
  • Epworth Sleepiness Scale (ESS): Question #8 score above "0" will prompt an additional question: Do you drive ("get behind the wheel") when you are drowsy? The answer must be "No" to be enrolled in the study due to safety concerns
  • Wireless Internet and two power outlets in sleeping location
  • Willingness not to use any other application which collects heart rate data on the phone and watch that is used for NightWare

Who cannot take part

  • Unstable medical condition (e.g., uncontrolled hypertension or active Cardiovascular disease (CVD) or cancer)
  • Active infection (note, anyone with an active infection would become eligible once the infection has ended)
  • Current history (past 3 months) of substance (excluding marijuana) or alcohol abuse per the SCID-5. Adults with past substance or alcohol use disorders will be allowed to participate
  • Diagnosis of active disorder of arousal from non-rapid eye movement sleep, rapid eye movement sleep behavior disorder, or narcolepsy
  • Diagnosis or suspicion of dementia
  • Seizure disorder
  • Participants experiencing severe cognitive impairment or current psychiatric symptoms of such severity that would preclude participation (e.g., active psychosis, imminently suicidal)
  • Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH)<0.5 or >5.0 milliunits per liter (mU/L); volunteers with abnormal thyroid stimulating hormone (TSH) values will be re-considered for participation in the study after follow-up evaluation by the Primary Care Provider (PCP) with initiation or adjustment of thyroid hormone replacement; or other problems that would interfere with participation in the study
  • Use of insulin or sulfonylureas
  • Pregnancy or currently breast feeding
  • Participants will be excluded if they report elevated acute risk for suicidal self-directed violence warranting immediate hospitalization (e.g., suicidal ideation with intent, evaluated by the Columbia-Suicide Severity Rating Scale [C-SSRS])
  • Shift workers (due to circadian rhythm disruption)
  • Nocturia that causes awakening from sleep
  • Known sleep walking or acting out dreams (contraindication to NightWare (NW) use)

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in United States.

  • Rocky Mountain Regional VA Medical Center, Aurora, COAurora, United StatesContact: Claire Cox, BSTaking people

About the trial

What the trial wants to find out

The purpose of this study is to learn more about the effectiveness of a prescription wrist-wearable device called NightWare (NW) on improving sleep in Veterans with nightmares related to posttraumatic stress disorder (PTSD). The investigators also want to learn whether it improves cardiovascular health among this population.

The 2 groups in the trial

  • NightWare activeTreatment being tested

    Intervention with NightWare Therapeutic System

    Treatment: NightWare

  • NightWare ShamSham treatment, for comparison

    NightWare app disabled; device will not deliver an intervention

    Treatment: NightWare

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Improving Cardiovascular Health in Veterans With PTSD by Treating Trauma-Related Nightmares With NightWare
Criteria questions
Built from NCT06419959, who can take part
Record updated
8 October 2026